Dose Escalation shows no benefit compared to continuing ABVD in Hodgkin's lymphoma patients with an interim PET deauville score of 4
Year: 2025
Type: conference-abstract
Source: Blood
Authors: Paloma Resende, Andre Meireles, Wysterlanyo Kayo Barros, Barbara Galvão, Norberto Kzan de Souza Neto, Aline Nishimoto, Carolina Pereira, Thais Oliveira, Larissa Teixeira, Carolina Feres, Fabio Santos, Ricardo Helman, João Guerra, Jose Kutner, Andreza Ribeiro, Leonardo Arcuri, Lucila Kerbauy, Mariana Kerbauy, Nelson Hamerschlak, Guilherme Perini
Institution: Hospital Israelita Albert Einstein
Language: English
Subfield: Pathology and Forensic Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4417004538
Cites:
Cited by:
Related to:
